STOCK TITAN

HeartCore Enterprises, Inc. SEC Filings

HTCR NASDAQ

Welcome to our dedicated page for HeartCore Enterprises SEC filings (Ticker: HTCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

HeartCore Enterprises, Inc. files regulatory reports that document material events for its IPO consulting business, capital structure, governance and Nasdaq listing status. Recent Form 8-K disclosures include operating-results releases, the treatment of HeartCore Co., Ltd. as discontinued operations following its divestiture, and information about the company’s transition toward financial services and capital markets-related activities.

The filings also record amendments to the company’s certificate of incorporation and bylaws, the completed reverse stock split, share-repurchase authorization, Regulation FD exhibits, and notices related to Nasdaq minimum bid price compliance for HTCR common stock.

Rhea-AI Summary

HeartCore Enterprises amended its S-1 to disclose an Equity Purchase Agreement with Crom Structured Opportunities Fund I, LP that gives the company the right to direct the accredited selling stockholder to sell up to $25,000,000 of newly issued common stock during a Commitment Period running from June 30, 2025 to June 30, 2027 (subject to termination conditions). The filing shows 23,310,770 shares outstanding as of August 28, 2025 and models issuance of 20,833,333 shares under the agreement (at an assumed $1.20/share) plus conversion of Series A preferred into 1,955,555 common shares (assumed $1.125/share), illustrating material potential dilution. The document also lists transaction fees and references incorporated financial statements and exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

HeartCore Enterprises, Inc. reports that Nasdaq has confirmed the company is back in compliance with the exchange’s minimum stockholders’ equity requirement. The company previously received a notice on May 24, 2025 stating it did not meet the $2,500,000 stockholders’ equity threshold and did not qualify under alternative market value or net income standards, although trading of its common stock on the Nasdaq Capital Market under the symbol HTCR was not immediately affected.

On August 19, 2025, Nasdaq reviewed HeartCore’s Form 10-Q for the period ended June 30, 2025, which showed stockholders’ equity of $3,559,017, and determined that the company now satisfies the equity listing rule and that the matter is closed. HeartCore also furnished a press release as an exhibit, providing additional communication about these developments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.84%
Tags
current report
-
Rhea-AI Summary

HeartCore Enterprises, Inc. reported that its Go IPO client, rYojbaba Co., Ltd., has begun trading on The Nasdaq Capital Market under the symbol “RYOJ.” This highlights activity in HeartCore’s Go IPO advisory and support business.

HeartCore received an aggregate of $500,000 in initial fees and warrants to acquire 3% of rYojbaba’s common stock on a fully diluted basis, valued at approximately $1.35 million as of August 14, 2025. The company furnished, but did not file, a press release describing these developments as an exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.29%
Tags
current report
Rhea-AI Summary

HeartCore Enterprises, Inc. disclosed that director Heather Neville will resign from the Board effective September 1, 2025, and that Prakash Sadasivam will resign as Chief Strategy Officer and as a director effective August 31, 2025. The filing explicitly states both resignations were not the result of any disagreement with the company on its operations, policies or practices.

These departures remove a sitting director and the company’s Chief Strategy Officer within days of each other. The filing does not identify successors, transitional arrangements, or additional context; HeartCore’s common stock trades on the Nasdaq Capital Market under the ticker HTCR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

HeartCore Enterprises, Inc. (HTCR) reported a strong quarterly turnaround for the three months ended June 30, 2025, with revenue of $4.74 million (up from $4.07 million a year earlier) and net income of $1.06 million, reversing a prior-year quarter loss. Gross profit widened to $2.22 million, aided by a $852,709 fair value gain on marketable securities and other investment revaluations.

For the six months ended June 30, 2025, revenue totaled $8.33 million (down from $9.11 million), producing a six-month net loss of $2.08 million. Operating cash flows used $2.67 million in the period. The company closed a securities purchase that generated $1.8 million net proceeds and issued a 2,000-share Series A convertible preferred designation, while also entering an equity purchase facility for up to $25 million. Key balance-sheet items include cash of $2.35 million, accounts receivable of $4.06 million and a $500,000 customer refund liability due August 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.06%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

Schedule 13G Highlights – Heartcore Enterprises, Inc. (HTCR)

Crom Structured Opportunities Fund I, LP (the “Reporting Person”) disclosed a 5.6 % beneficial ownership of Heartcore Enterprises, Inc. common stock as of 30 June 2025. The filing, made on 14 July 2025, triggers Schedule 13G reporting because the stake exceeds the 5 % threshold.

  • Shares owned: 1,235,437 common shares
  • Sole voting & dispositive power: 1,235,437 shares; no shared power
  • Convertible preferred: The fund also holds 2,000 Series A Convertible Preferred shares. Conversion is subject to a 4.99 % ownership blocker, so no additional common shares are currently counted.
  • Ownership basis: Percentage calculated against 22,075,033 outstanding common shares (Issuer data as of 15 May 2025).
  • Intent: The certification states the securities were not acquired to influence control of the issuer, indicating a passive investment posture.

Investor Significance

The appearance of a new 5 %+ holder can be material for market perception, signalling external interest in HTCR’s equity. However, the filing contains no information on purchase price, strategic plans or future transactions. Potential dilution could arise if the 4.99 % blocker is waived and the preferred shares are converted, but that would require a separate filing once the threshold is crossed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.29%
Tags
current report

FAQ

How many HeartCore Enterprises (HTCR) SEC filings are available on StockTitan?

StockTitan tracks 30 SEC filings for HeartCore Enterprises (HTCR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for HeartCore Enterprises (HTCR)?

The most recent SEC filing for HeartCore Enterprises (HTCR) was filed on August 29, 2025.